Our Clinical Trials Unit (CTUs) fosters innovation to shape the future of health care. CTUs are specialized departments within institutions that conduct vital testing prior to the delivery of treatment to patients. From safety assessments to large-scale effectiveness studies, they meticulously plan and conduct trials to ensure scientific integrity. Wearable devices and data analytics enable CTUs to perform more efficient, patient-centered trials through the fusion of tradition and innovation.

By discovering and demonstrating breakthroughs, CTUs serve as the cornerstone of medical progress and illustrate the impact of science on patient care. At our Clinical Trials Unit, research and collaboration open the door to new possibilities, transforming health care.

Paving the way for innovation

We launched one of the first clinical trials units in the UAE, conducting phase II and phase III trials on Jan. 17, 2023, with the aim of bridging the gap between scientific discovery and patient care.


Our mission

We are committed to assisting, streamlining and advancing high-caliber, innovative research that adheres to the highest scientific and operational standards. In accordance with the International Conference on Harmonization-Good Clinical Practice (ICH-GCP) guidelines, we strive to maximize patient outcomes.

Defining excellence through collaboration: The CTU team

Our team is led by a group of visionary minds and experts:
  • Operations administrator
  • Medical director of research
  • Project manager
  • Operations manager
  • Finance manager
  • Biostatistician
  • Clinical research pharmacist
  • Clinical research coordinators
  • Clinical research nurse
To ensure the safety of participants, all trials are conducted according to strict protocols and ethical guidelines.

Types of clinical research studies supported by the CTUs:

  • Interventional clinical trials: Phase I, phase II, phase III and phase IV
  • Observational studies:
    • RWE studies
    • Prospective cohort
    • Retrospective chart review
    • Cross-sectional survey
  • Disease-specific registries
  • Artificial intelligence (AI) and machine learning

Data management (DM)

In addition to managing research data for investigator-initiated studies, the CTUs also offer services for the management of clinical trials, registries, surveys and other forms of research data. For each case report form (CRF), we design and develop customized electronic databases, ensure the data reported is accurate and verifiable, oversee the extraction of clinical results, complete the study CRF forms and prepare a statistical analysis of the data.
In our CTUs, we utilize the REDCap software to construct databases, ensuring both accuracy and security.


Statistical analysis and consultation services are provided by the CTUs for all research projects approved by the Scientific Advisory Council (SAC). As well as providing support during data analysis and reporting, we assist researchers with sample size, study design and statistical methodology planning.

Research subjects

Trial participants contribute to the progress of medical science by facilitating the development of new treatments, therapies and interventions.

The current clinical trial studies available have individual eligibility requirements. Interested participants can determine their eligibility and ask any questions regarding participation through the clinical study listing, which provides information on eligibility.

Participation in a clinical trial is voluntary and refusal to participate does not have any impact on routine medical care. Participants may leave a study at any time and for any reason after enrolling in a clinical trial.

Informed consent in clinical trials

Participation in clinical trials at SSMC is entirely voluntary; an informed consent form (ICF) will be provided to each potential participant to ensure ethical and compliant research. ICFs provide a detailed description of the trial, including its purpose, procedures, risks, benefits, rights and alternatives, which allow individuals to make an informed decision about whether or not to participate. While participants must sign the ICF to enroll, they are free to withdraw from the trial at any time.


How are research subjects protected?

The SSMC Institutional Review Board (IRB) is an administrative body responsible for safeguarding the rights and welfare of all human research participants. To ensure that all research by SSMC is conducted safely and ethically, this independent organization continuously monitors and reviews all research activities.

The Scientific Advisory Committee (SAC)

The Scientific Advisory Committee (SAC) affirms the scientific merit of research and ensures rigorous statistical review in order to maintain SSMC’s integrity and credibility in research.

Learn more

Ongoing Trials

# Study Title Type Disease Principal Investigator Domain Sponsor Participation

SSMC’s Research

Learn more

SSMC’s Institutional Review Board (IRB)

Learn more

Research Highlights and News

Learn more

Frequently Asked Questions (FAQ’s)

Learn more

For Research Participants

Learn more

Contact us

For inquiries regarding clinical trials at SSMC, please contact [email protected]. This includes queries on whether you are eligible to enroll in clinical trials at SSMC.

Powered by Ajaxy